| Factor Information | |
|---|---|
| Data ID | 3826 |
| Factor | the frequency of cardioversion after ablation |
| Description | After ablation, the frequency of cardioversion in those patients with recurrence reverted to a level that was lower than that experience during the 24 months before ablation (0.072 vs. 0.181 cardioversions per patient-month, p =0.0004) |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | The objective of the study was to determine the early and midterm success rates of RF ablation in effecting a reduction of clinical arrhythmic events in patients with IART and CHD. |
| p Value | 0.0004 |
| Conclusion | After ablation, the frequency of cardioversion in those patients with recurrence reverted to a level that was lower than that experience during the 24 months before ablation (0.072 vs. 0.181 cardioversions per patient-month, p =0.0004) |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 712 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF, VSD/TGA/ASD/SV/CHD/other |
| Reference | |
|---|---|
| PMID | 9316535 |
| Year | 1997 |
| Title | Efficacy of Radiofrequency Ablation for Control of Intraatrial Reentrant Tachycardia in Patients With Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | Clinical records | |
| Region | Massachusetts, USA. | |
| Method | analyzed retrospectively | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | VSD repair/ASD repair/unrepaired | |
| Group | patients with recurrence(Treatment) | patients with recurrence experience during the 24 months before ablation(Control) |
| Number | 7 | 14 |
| Age | 24.5 ± 10.5 years [range 7.9 to 44.8] | 24.5 ± 10.5 years [range 7.9 to 44.8] |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.072 | 0.181 |
